Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Concomitant versus sequential administration of epirubicin and paclitaxel as first‐line therapy in metastatic breast carcinoma

PaperCitations, authors & open-access status

Concomitant versus sequential administration of epirubicin and paclitaxel as first‐line therapy in metastatic breast carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 69 citations, 2004 year and bronze oa status.

69
Citations
2004
Year
bronze
OA Status

Related on ScholarIQ

Angelo Bolognesi
Author
Cancer
Journal
Cancer Treatment and Pharmacology
Topic
Cancer Treatment and Pharmacology
Topic
Breast Cancer Treatment Studies
Topic
Chemotherapy-induced cardiotoxicity and mitigation
Topic
470M+ articles · free account